MiMedx Group, Inc (MDXG) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
18/25
Growth 5
Margin 3
Expansion 5
Platform 1
Financial 4
latest quarter score
Earnings Reports
- 18
- 12
- 15
-
21
MiMedx (MDXG) Q3 2025: Wound Sales Jump 40% as Medicare Reform LoomsOctober 30, 2025
- 23
- 6